Jean Fraisse, MD

Articles by Jean Fraisse, MD

Impact of UFT on Tumoral TS and DPD Levels in Colorectal Cancer

ByGerard Bastian, PhD,Jean-franÇois Seitz, MD,Vincent Moutardier, MD,Jean Robert Delperro, MD,Pierre Fargeot, MD,Jean Fraisse, MD,Patricia Formento, PhD,Michel Chazard, MD,Nicole Renée, PhD,Gerard Milano, PhD

This was an open lable, pilot translational clinical pharmacology study of a brief (7 day) course of UFT, 300 mg/m²/day, in combination with leucovorin, 90 mg/day, in six patients with newly diagnosed advanced colorectal cancer.

Latest Updated Articles